Advertisement

Topic: Qnexa

Jump to

Latest Headlines

Health News // 1 decade ago

FDA to consider new weight-loss drug

Documents released by the U.S. Food and Drug Administration indicate it has concerns the weight-loss drug Qnexa might cause birth defects and heart problems.

Science News // 1 decade ago

FDA rejects diet drug approval

The U.S. Food and Drug Administration has denied approval of the weight-loss drug Contrave, the third similar drug it has kept off the market in recent months.

Science News // 1 decade ago

UPI NewsTrack Health and Science News

'Universal' flu vaccine being developed ... 2010: Warmest year on record? ... Obesity drug fails to win approval ... Robotic legs allow paraplegics to walk ... Health/Science news from UPI.

Health News // 1 decade ago

Obesity drug fails to win approval

A U.S. drug advisory panel turned thumbs down on a new drug to treat obesity because of health concerns, said a panel member.

Health News // 1 decade ago

FDA may approve obesity drug Qnexa

Review documents released by the U.S. Food and Drug Administration indicate the obesity drug Qnexa may be approved, but there are side-effect concerns.

Science News // 1 decade ago

UPI NewsTrack Health and Science News

Study: Cellphone use fights Alzheimer's ... Obesity drug said to reduce sleep apnea ... San Fran's famous sea lions now in Oregon ... Earthlike exoplanet evaporating near star ... Health/Science news from UPI.

Health News // 1 decade ago

Obesity drug said to reduce sleep apnea

U.S. drug-development company Vivus Inc. said Thursday a clinical study showed its obesity drug Qnexa helped reduce sleep apnea by increasing weight loss.

Health News // 1 decade ago

New drug promotes weight loss in obese

A California biopharmaceutical company has submitted a government application for a new weight-loss drug, officials said Tuesday.

Health News // 1 decade ago

3 new diet pills race to hit market

Three pharmaceutical companies are racing to get their new diet pills to market first, drug company scientists said.

Health News // 1 decade ago

Vivus to retest female arousal drug

U.S. firm Vivus' topical drug Alista, a therapy for female sexual arousal disorder, will be retested in women who have had hysterectomies.

The combination of the drugs phentermine and topiramate (trade name Qnexa) is an investigational medication for the treatment of obesity and related conditions such as type 2 diabetes and has been found to lower blood pressure and cholesterol.[1] Qnexa is being developed by Vivus, a California pharmaceutical company.[2] Phentermine is an appetite suppressant and stimulant of the amphetamine and phenethylamine class. Topiramate is an anticonvulsant that has weight loss side effects.

FULL ARTICLE AT WIKIPEDIA.ORG

This article is licensed under the GNU Free Documentation License.
It uses material from the Wikipedia article "Qnexa."